IDXX FY 2024 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

IDXXIDEXX Laboratories, Inc.

$48B

FY 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$3.9B+6.5% YoY

Gross Profit

$2.4B61.0% margin

Operating Income

$1.1B29.0% margin

Net Income

$888M22.8% margin

EPS (Diluted)

$10.67

Cash Flow

Operating Cash Flow

$929M

Free Cash Flow

$798M

Stock-Based Comp.

$60M

Balance Sheet

Total Assets

$3.3B

Total Liabilities

$1.7B

Stockholders' Equity

$1.6B

Cash & Equivalents

$288M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.9B	$3.7B	+6.5%
Gross Profit	$2.4B	$2.2B	+8.6%
Operating Income	$1.1B	$1.1B	+2.8%
Net Income	$888M	$845M	+5.1%